Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00423332What this trial is testingCediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma AstraZeneca 105
Not applicableActive Not RecruitingNCT02735252What this trial is testingPROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerWho this might be right forProstate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma+1 more University of California, San Francisco 156
Early research (Phase 1)Ended earlyNCT03138538What this trial is testingM8891 First in Human in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Renal Cell Carcinoma EMD Serono Research & Development Institute, Inc. 27
Early research (Phase 1)UnknownNCT06182735What this trial is testingCD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Fudan University 9
Early research (Phase 1)Looking for participantsNCT06805825What this trial is testingThe c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitWho this might be right forGastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more Novelty Nobility, Inc. 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223What this trial is testingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyWho this might be right forAdvanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT03587662What this trial is testingIxazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forMetastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT05096390What this trial is testingAxitinib +/- Pembrolizumab in First Line Treatment of mPRCCWho this might be right forPapillary Renal Cell Carcinoma Type 2 Centre Leon Berard 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04413123What this trial is testingCabozantinib In Combo With NIVO + IPI In Advanced NCCRCCWho this might be right forPapillary Renal Cell CarcinomaUnclassified Renal Cell CarcinomaTranslocation Renal Cell Carcinoma+5 more Bradley A. McGregor, MD 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT03141177What this trial is testingNivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 701
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Testing effectiveness (Phase 2)Study completedNCT03163667What this trial is testingCB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)Who this might be right forClear Cell Renal Cell Carcinoma Calithera Biosciences, Inc 69
Early research (Phase 1)Study completedNCT01844947What this trial is testingPhase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractWho this might be right forUrothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more Dr Anders Ullén 22
Testing effectiveness (Phase 2)UnknownNCT05013099What this trial is testingStudy of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic MalignanciesWho this might be right forMelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more ImaginAb, Inc. 70
Not applicableWithdrawnNCT04941365What this trial is testingQuantifying Systemic Immunosuppression to Personalize Cancer TherapyWho this might be right forMetastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more Institut du Cancer de Montpellier - Val d'Aurelle
Not applicableUnknownNCT05135832What this trial is testingPatient Reported Outcomes by Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaKidney CancerKidney Neoplasm+3 more Herlev and Gentofte Hospital 174
Testing effectiveness (Phase 2)UnknownNCT01444807What this trial is testingEvaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the MetastasesWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 132